| dc.contributor.author | Cheong, Yuen Yi | |
| dc.date.accessioned | 2021-08-24T23:33:16Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Cheong, Yuen Yi. Ibrutinib versus bendamustine plus rituximab in first-line treatment for elderly patients of chronic lymphocytic leukemia- A cost-utility analysis in a Norwegian setting. Master thesis, University of Oslo, 2021 | |
| dc.identifier.uri | http://hdl.handle.net/10852/87166 | |
| dc.description.abstract | | eng |
| dc.language.iso | eng | |
| dc.subject | | |
| dc.title | Ibrutinib versus bendamustine plus rituximab in first-line treatment for elderly patients of chronic lymphocytic leukemia- A cost-utility analysis in a Norwegian setting | eng |
| dc.type | Master thesis | |
| dc.date.updated | 2021-08-25T22:21:55Z | |
| dc.creator.author | Cheong, Yuen Yi | |
| dc.date.embargoenddate | 3021-05-18 | |
| dc.rights.terms | Dette dokumentet er ikke elektronisk tilgjengelig etter ønske fra forfatter. Tilgangskode/Access code A | |
| dc.identifier.urn | URN:NBN:no-89742 | |
| dc.type.document | Masteroppgave | |
| dc.rights.accessrights | closedaccess | |
| dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/87166/5/Thesis_Final_18May2021_Yuen-Yi-Cheong.pdf | |